Related Experiment Video
Updated: Apr 7, 2026

Author Spotlight: Rabies-Specific Antibody Isotypes Detection in Sera or Cerebral Spinal Fluid Using an IFA Test
Published on: January 19, 2024
A Case of Immune Thrombocytopenic Purpura After Rabies Vaccination
Joy M Fulbright1, Sarah E Williams, Barbara A Pahud
1*Division of Hematology/Oncology ‡Division of Infectious Diseases, Children's Mercy Hospital, Kansas City, MO †Division of General Pediatrics, Vanderbilt University School of Medicine, Nashville, TN.
Abstract:
We describe a case of immune thrombocytopenic purpura (ITP) occurring 15 days after the first dose of a 4-dose rabies vaccination series. ITP is thought to be an immune-mediated process triggered by an infection or toxin. There is little evidence in the literature beyond case reports of an association of ITP with vaccines other than with the measles, mumps, and rubella vaccine. This is the third reported case of ITP associated with rabies vaccination. Because of the rare occurrence of this adverse event relative to the severity of rabies infection, the benefits of rabies vaccination, when indicated, outweigh the low and possible risk of ITP.

